Detection of Synaptic Vesicle Glycoprotein 2A in Serum Using a Polypyrrole-Functionalized Graphene Oxide...

Early intervention is pivotal for mitigating the progression of Alzheimer's disease (AD). This study presents an electrochemical immunosensor targeting synaptic vesicle glycoprotein 2A (SV2A) to facilitate early AD diagnosis. A sensing interface was engineered using a nanocomposite of graphene oxide (GO) and 3-carboxyl polypyrrole (3-COOH-PPy). Leveraging the synergistic effects between the large specific surface area of GO and the superior conductivity of 3-COOH-PPy, the composite established an efficient electron transport network. This architecture provided abundant active sites for capture antibody immobilization while significantly enhancing interfacial electron transfer kinetics. Coupling this interface with an enzyme-mediated signal amplification strategy based on the horseradish peroxidase (HRP)-catalyzed TMB/H₂O₂ system, the immunosensor achieved high sensitivity. It exhibited a wide linear range of 2 ng/mL to 16 μg/mL with a low limit of detection (LOD) of 0.15 ng/mL. Furthermore, successful detection in C57 mouse serum samples validated the method's reliability and potential for clinical application. In conclusion, this immunosensor offers a sensitive and robust platform for the early diagnosis of AD.